An old friend: 25 years of meloxicam use in Russia.
25 years ago, a new non-steroidal anti-inflammatory drug (NSAID) – meloxicam (Movalis®) – entered the clinical practice of our country. This drug was the first embodiment of the concept of selective blockade of cyclooxygenase 2 – the main pathway followed by pharmacological science to create a safe...
Main Authors: | A. E. Karateev, E. L. Nasonov, E. Yu. Pogozheva, E. S. Filatova, V. N. Amirdzhanova, V. A. Nesterenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-07-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3042 |
Similar Items
-
Meloxicam in Russia: 20 years together
by: A E Karateev, et al.
Published: (2016-12-01) -
Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01) -
Control of pain in the early post-traumatic period in the outpatient practice. Results of the multi-center observational study RAPTOR (Rational Analgesia PostTraumatic: an Observational Research)
by: A. E. Karateev, et al.
Published: (2020-06-01) -
A sound approach to choosing nonsteroidal anti-inflammatory drugs for osteoarthritis
by: E. V. Zonova, et al.
Published: (2018-12-01) -
Factors influencing the efficacy of nonsteroidal anti-inflammatory drugs for acute low back pain. The results of the multicenter observational «CARAMBOL» (Clinical Analysis of Results of Analgesia by Meloxicam and its Safety in Acute Lumbodynia) study
by: A. E. Karateev, et al.
Published: (2019-05-01)